Cita APA

Tutusaus, A., Stefanovic, M., Boix i Ferrero, L., Cucarull, B., Zamora, A., Blasco, L., . . . Morales Muñoz, A. (2018). Antiapoptotic BCL-2 proteins determine Sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.

Citación estilo Chicago

Tutusaus, Anna, et al. Antiapoptotic BCL-2 Proteins Determine Sorafenib/regorafenib Resistance and BH3-mimetic Efficacy in Hepatocellular Carcinoma. 2018.

Cita MLA

Tutusaus, Anna, et al. Antiapoptotic BCL-2 Proteins Determine Sorafenib/regorafenib Resistance and BH3-mimetic Efficacy in Hepatocellular Carcinoma. 2018.